Cargando…
killerFLIP: a novel lytic peptide specifically inducing cancer cell death
One of the objectives in the development of effective cancer therapy is induction of tumor-selective cell death. Toward this end, we have identified a small peptide that, when introduced into cells via a TAT cell-delivery system, shows a remarkably potent cytoxicity in a variety of cancer cell lines...
Autores principales: | Pennarun, B, Gaidos, G, Bucur, O, Tinari, A, Rupasinghe, C, Jin, T, Dewar, R, Song, K, Santos, M T, Malorni, W, Mierke, D, Khosravi-Far, R |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3920952/ https://www.ncbi.nlm.nih.gov/pubmed/24176852 http://dx.doi.org/10.1038/cddis.2013.401 |
Ejemplares similares
-
A novel caspase 8 selective small molecule potentiates TRAIL-induced cell death
por: Bucur, Octavian, et al.
Publicado: (2015) -
Identification and Characterization of the Interaction Site between cFLIP(L) and Calmodulin
por: Gaidos, Gabriel, et al.
Publicado: (2015) -
Combination of Bortezomib and Mitotic Inhibitors Down-Modulate Bcr-Abl and Efficiently Eliminates Tyrosine-Kinase Inhibitor Sensitive and Resistant Bcr-Abl-Positive Leukemic Cells
por: Bucur, Octavian, et al.
Publicado: (2013) -
Analysis of apoptosis methods recently used in Cancer Research and Cell Death & Disease publications
por: Bucur, O, et al.
Publicado: (2012) -
Activation of Cyclin-Dependent Kinase 5 Is a Consequence of Cell Death
por: Ye, Yixia, et al.
Publicado: (2009)